Skip to main content
David Steinhaus, MD, Cardiology, Minneapolis, MN

DavidMichaelSteinhausMD

Cardiology Minneapolis, MN

Adult Congenital Heart Disease, Cardiac Electrophysiology

Vice President Medtronic

Dr. Steinhaus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Steinhaus' full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1983 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 1980 - 1983
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
  • Harvard Medical School
    Harvard Medical SchoolClass of 1977

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2006 - 2025
  • MO State Medical License
    MO State Medical License 1984 - 2025
  • KS State Medical License
    KS State Medical License 1996 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA Approval
    Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA ApprovalAugust 9th, 2018
  • Medtronic, United Receive Approval for Fully Implantable PAH Infusion Pump
    Medtronic, United Receive Approval for Fully Implantable PAH Infusion PumpAugust 1st, 2018
  • FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAH
    FDA Approves Medtronic’s Implantable System for Remodulin to Treat PAHAugust 1st, 2018
  • Join now to see all

Professional Memberships